Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.
Kellee ParkerErika CottrellLinda StorkSusan LindemulderPublished in: Pediatric blood & cancer (2021)
While many parents recognize the importance of clinical trials aiming to mitigate side effects, the fear of their own child relapsing with less than standard therapy may dissuade them from study participation. Recognizing and addressing these concerns will be important for enrollment and retention in future clinical trials.